Research and experimental development on natural sciences and engineering
ADJUTEC PHARMA AS
Operating profit
NOK −2.1m
Equity
NOK 33.3m
Incorporated
2019
Employees
5
Share capital
NOK 58,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating costs | 2.1m | |
| Operating profit (EBIT) | −2.1m | |
| Net financial items | 220k | |
| Profit for the year | −1.5m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 43.4m | |
| of which current assets | 8.5m | |
| Equity | 33.3m | |
| Total liabilities | 10.1m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.